Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension

<b>Background/Objectives</b>: The loss of retinal ganglion cells (RGCs) is a hallmark of glaucoma, a major cause of blindness. Glial cell activation due to increased intraocular pressure (IOP) significantly contributes to RGC death. Therefore, substances with anti-inflammatory properties...

Full description

Bibliographic Details
Published in:Pharmaceuticals
Main Authors: José A. Matamoros, Sara Rubio-Casado, José A. Fernández-Albarral, Miguel A. Martínez-López, Ana I. Ramírez, Elena Salobrar-García, Eva M. Marco, Victor Paleo-García, Rosa de Hoz, Inés López-Cuenca, Lorena Elvira-Hurtado, Lidia Sánchez-Puebla, José M. Ramírez, Meritxell López-Gallardo, Juan J. Salazar
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Subjects:
ocular hypertension
retina
visual pathway
glial cells
Citicoline
Coenzyme Q10
Online Access:https://www.mdpi.com/1424-8247/18/5/694

Internet

https://www.mdpi.com/1424-8247/18/5/694

Similar Items